Ascendis Pharma A/S (ASND)
253.38
+1.43
(+0.57%)
USD |
NASDAQ |
Aug 25, 16:00
253.38
0.00 (0.00%)
After-Hours: 18:49
Ascendis Pharma Market Cap : 16.64B for Aug. 25, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 24, 2026 | 16.55B |
| August 21, 2026 | 16.63B |
| August 20, 2026 | 16.73B |
| August 19, 2026 | 17.05B |
| August 18, 2026 | 16.34B |
| August 17, 2026 | 16.25B |
| August 14, 2026 | 16.32B |
| August 13, 2026 | 16.17B |
| August 12, 2026 | 16.78B |
| August 11, 2026 | 16.72B |
| August 10, 2026 | 16.79B |
| August 07, 2026 | 15.86B |
| August 06, 2026 | 15.52B |
| August 05, 2026 | 15.17B |
| August 04, 2026 | 15.19B |
| August 03, 2026 | 15.12B |
| July 31, 2026 | 15.15B |
| July 30, 2026 | 15.59B |
| July 29, 2026 | 15.66B |
| July 28, 2026 | 15.80B |
| July 27, 2026 | 15.74B |
| July 24, 2026 | 15.77B |
| July 23, 2026 | 15.69B |
| July 22, 2026 | 15.65B |
| July 21, 2026 | 15.85B |
| Date | Value |
|---|---|
| July 20, 2026 | 15.64B |
| July 17, 2026 | 16.21B |
| July 16, 2026 | 16.14B |
| July 15, 2026 | 16.68B |
| July 14, 2026 | 16.49B |
| July 13, 2026 | 16.47B |
| July 10, 2026 | 16.80B |
| July 09, 2026 | 17.11B |
| July 08, 2026 | 17.22B |
| July 07, 2026 | 16.58B |
| July 06, 2026 | 16.64B |
| July 02, 2026 | 17.05B |
| July 01, 2026 | 16.63B |
| June 30, 2026 | 16.57B |
| June 29, 2026 | 16.38B |
| June 26, 2026 | 16.20B |
| June 25, 2026 | 16.25B |
| June 24, 2026 | 14.78B |
| June 23, 2026 | 14.82B |
| June 22, 2026 | 14.16B |
| June 18, 2026 | 14.34B |
| June 17, 2026 | 14.36B |
| June 16, 2026 | 14.36B |
| June 15, 2026 | 13.87B |
| June 12, 2026 | 13.54B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Evaxion AS | 28.27M |
| Genmab A/S | 20.51B |
| Zealand Pharma A/S | 3.368B |
| Cellectis SA | 344.39M |
| BioMarin Pharmaceutical, Inc. | 12.80B |
Market Cap Related Metrics
| PE Ratio | 19.31 |
| PS Ratio | 13.23 |
| Price to Book Value | 10.13 |
| Price to Free Cash Flow | 41.54 |
| Price | 253.38 |
| Earnings Yield | 5.18% |
| Operating PE Ratio | 128.24 |
| Normalized PE Ratio | 19.31 |